Intelligent Bio Solutions Inc. (INBS) Ownership
INBS ownership summary
as of October 17, 2026- Institutions
- 5.5% of shares outstanding
- Insiders
- 2.73% of shares outstanding
- Shares outstanding
- 3.3M
- Float
- 2.9M shares available to trade
- Short interest
- 1.81% 58K shares short
- Days to cover
- 0.21 short interest down 51.2% vs prior month
- Institutions 5.47%
- Insiders 2.73%
- Other investors 91.80%
INBS top institutional holders
14 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Armistice Capital, LLC | 4.26% | 141K | $212,096 | +11,397 (+8.8%) | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.63% | 21K | $31,260 | −7,769 (−27.2%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 0.18% | 5,810 | $8,715 | — | June 30, 2026 |
| 4 | UBS Group AG | 0.17% | 5,735 | $8,602 | +5,363 (+1,441.7%) | June 30, 2026 |
| 5 | Vanguard Fiduciary Trust Co | 0.12% | 3,958 | $5,937 | — | June 30, 2026 |
| 6 | Tower Research Capital LLC | 0.10% | 3,280 | $4,920 | +2,030 (+162.4%) | June 30, 2026 |
| 7 | Advisor Group Holdings, Inc. | 0.01% | 200 | $300 | — | June 30, 2026 |
| 8 | Barclays PLC | <0.01% | 142 | $213 | +142 (0.0%) | June 30, 2026 |
| 9 | SHP Wealth Management | 0.00% | — | — | −25 (−100.0%) | March 31, 2026 |
| 10 | CURIO WEALTH, LLC | 0.00% | — | — | −200 (−100.0%) | June 30, 2026 |
| 11 | Citigroup Inc | 0.00% | — | — | −76 (−100.0%) | March 31, 2026 |
| 12 | NATIONAL BANK OF CANADA /FI/ | 0.00% | — | — | −35 (−100.0%) | March 31, 2026 |
| 13 | Alyeska Investment Group, L.P. | 0.00% | — | — | −37,956 (−100.0%) | June 30, 2026 |
| 14 | Bank of America Corp | 0.00% | — | — | −9 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 14, 4 holders added 19K shares and 7 cut 46K.
INBS top mutual fund and ETF holders
4 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.38% | 12K | $18,717 | −67 (−0.5%) | August 31, 2026 |
| 2 | Fidelity Nasdaq Composite Index | 0.08% | 2,537 | $3,806 | — | August 31, 2026 |
| 3 | Fidelity Series Total Market Index | 0.05% | 1,769 | $2,654 | — | August 31, 2026 |
| 4 | Fidelity Total Market Index | 0.01% | 409 | $614 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
INBS insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-08-31 | Harry Simeonidis | Buy | $230.40 | — | — |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
INBS shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns INBS
Institutional investors own 5.5% of Intelligent Bio Solutions's shares and insiders 2.73%. The largest holder is Armistice Capital, LLC with 4.26% of the shares (141K), as of June 30, 2026. Among the top 14 institutions, 4 added shares and 7 reduced their stake in the latest filings. Short interest is 1.81% of the float, or 0.21 days of average trading volume. The share count rose 27,864.7% since 2017.
Related: INBS analyst forecast, INBS key metrics. See the INBS stock overview for the latest quote and news.
INBS ownership FAQ
Who owns the most Intelligent Bio Solutions stock?
The largest shareholders of Intelligent Bio Solutions are Armistice Capital, LLC (4.26%), Geode Capital Management, LLC (0.63%), Vanguard Capital Management, LLC (0.18%), UBS Group AG (0.17%), Vanguard Fiduciary Trust Co (0.12%).
What percentage of Intelligent Bio Solutions is owned by institutions?
Institutions hold 5.5% of Intelligent Bio Solutions's shares outstanding; insiders hold 2.73%.
Which funds own Intelligent Bio Solutions?
The largest fund holders of Intelligent Bio Solutions are Fidelity Extended Market Index (0.38%), Fidelity Nasdaq Composite Index (0.08%), Fidelity Series Total Market Index (0.05%), Fidelity Total Market Index (0.01%).
What is Intelligent Bio Solutions's short interest?
58K shares of Intelligent Bio Solutions were sold short, 1.81% of the float; at the average daily volume it would take 0.21 days to cover.
Are insiders buying or selling Intelligent Bio Solutions?
Of the latest 1 reported insider transactions in Intelligent Bio Solutions (since August 31, 2023), 1 were purchases and 0 were sales.
How many shares of Intelligent Bio Solutions are outstanding?
Intelligent Bio Solutions has 3.3M shares outstanding, of which 2.9M are in the public float.